37972-07-9

Basic information

• Product Name: 2,7-bis[5-(piperidin-1-yl)pentanoyl]-9H-xanthen-9-one
• Synonyms: 9H-Xanthen-9-one, 2,7-bis[1-oxo-5-(1-piperidinyl)pentyl]-
• CAS NO: 37972-07-9
• Molecular Formula: C₃₃H₄₂N₂O₄
• Molecular Weight: 530.6976
• Mol File: 37972-07-9.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 679.7°C at 760 mmHg
• Flash Point: 364.8°C
• Density: 1.146g/cm³
• Vapor Pressure: 2.5E-18mmHg at 25°C
• Refractive Index: 1.573
• CAS DataBase Reference: 2,7-bis[5-(piperidin-1-yl)pentanoyl]-9H-xanthen-9-one(CAS DataBase Reference)
• NIST Chemistry Reference: 2,7-bis[5-(piperidin-1-yl)pentanoyl]-9H-xanthen-9-one(37972-07-9)
• EPA Substance Registry System: 2,7-bis[5-(piperidin-1-yl)pentanoyl]-9H-xanthen-9-one(37972-07-9)

Safety Data

• Hazardous Substances Data: 37972-07-9(Hazardous Substances Data)

Usage

Chemical Class

The compound belongs to the xanthene class of organic compounds.

Primary Use

BXPX is primarily used as a fluorescent probe in various biochemical and cell biology research applications.

Labeling Molecule

It is often utilized as a labeling molecule to visualize cellular structures and processes, such as membrane dynamics, protein trafficking, and intracellular signaling.

Fluorescence

2,7-bis[5-(piperidin-1-yl)pentanoyl]-9H-xanthen-9-one's ability to fluoresce under specific wavelength excitation makes it a valuable tool for studying and understanding complex biological systems.

Chemical Structure

Its chemical structure, with multiple piperidine groups, allows for interactions with biological targets.

Versatility

This makes BXPX a versatile and powerful tool in molecular imaging and biological research.

Upstream product

• 37972-05-7 5,5'-di-piperidin-1-yl-1,1'-xanthene-2,7-diyl-bis-pentan-1-one 
• 1078-71-3 heptylbenzene 

Relevant articles and documents

Antiviral compositions containing bis-basic ketones of xanthene and xanthen-9-one

Novel bis-basic ketones of xanthene and xanthen-9-one have antiviral activity when administered orally and parenterally. The compounds are represented by the following formula: SPC1 Wherein Z is oxygen or H2 ; each A is a straight or branched alkylene chain having from 1 to about 6 carbon atoms; and each Y is A. the group EQU1 wherein R1 and R2 are individually hydrogen, lower alkyl having from 1 to about 6 carbon atoms, cycloalkyl having from 3 to 6 carbon atoms, alkenyl of from 3 to 6 carbon atoms and having the vinyl unsaturation in other than the 1-position of the alkenyl group; or B. the group EQU2 WHEREIN N IS A WHOLE INTEGER FROM 4 TO 6, AND R3 is hydrogen, lower alkyl of from 1 to about 4 carbon atoms and can be linked to any one of the carbon atoms of the heterocyclic group; or C. the group EQU3 wherein X is oxygen or NR4, and R4 is hydrogen or lower alkyl of from 1 to about 4 carbon atoms; Or a pharmaceutically acceptable acid addition salt thereof. These compounds can be prepared by several different methods.